Knowledge Distillery

Although some studies have shown neuroimaging and neuropsychological alterations in post-COVID-19 patients, fewer combined neuroimaging and…

The purpose of this prospective cohort study was to evaluate the possible correlation between SARS-CoV-2 vaccines and the onset of neurological…

The aim of this systematic review and meta-analysis was to evaluate the prevalence of thirteen neurological manifestations in people affected by…

The temporal association between the occurrence of neurological diseases, many autoimmune diseases, and vaccination against SARS-CoV-2 has been…

Despite the high prevalence and major disability associated with fatigue and cognitive deficits after SARS-CoV-2 infection, little is known about…

Epidemiological studies showed that COVID-19 increases risk of Alzheimer's disease (AD). However, it remains unknown if there is a potential genetic…

Fatigue is a frequent and one of the most debilitating symptoms in post-COVID syndrome (PCS). Recently, the authors of this article proposed that…

Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce. In this…

Infection with COVID-19 can lead to persistent sequelae, such as fatigue, daytime sleepiness or disturbed sleep, that can remain for more than 12…

Hitherto no therapeutic has received regulatory approval for the treatment of Post-COVID-19 Condition (PCC). Cognitive deficits, mood symptoms, and…

A variety of neurologic disorders have been reported as presentations or complications of coronavirus disease 2019 (COVID-19) infection.

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), rapidly spread across the globe.